Dihydromyricetin promotes longevity and activates the transcription factors FOXO and AOP in Drosophila

Aging (Albany NY). 2020 Dec 3;13(1):460-476. doi: 10.18632/aging.202156. Epub 2020 Dec 3.

Abstract

Drugs or compounds have been shown to promote longevity in various approaches. We used Drosophila to explore novel natural compounds can be applied to anti-aging. Here we reported that a flavonoid named Dihydromyricetin can increase stress that tolerance and lipid levels, slow down gut dysfunction and extend Drosophila lifespan. Dihydromyricetin can also lessen pERK and pAKT signaling, consequently activating FOXO and AOP to modulate longevity. Our results suggested that DHM could be used as an effective compound for anti-aging intervention, which could likely be applied to both mammals and humans.

Keywords: AKT; Dihydromyricetin; ERK; FOXO; anti-aging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects*
  • Aging / metabolism
  • Animals
  • Drosophila Proteins / drug effects*
  • Drosophila Proteins / metabolism
  • Drosophila melanogaster
  • Eye Proteins / drug effects*
  • Eye Proteins / metabolism
  • Flavonols / pharmacology*
  • Forkhead Transcription Factors / drug effects*
  • Forkhead Transcription Factors / metabolism
  • Longevity / drug effects*
  • Repressor Proteins / drug effects*
  • Repressor Proteins / metabolism

Substances

  • AOP protein, Drosophila
  • Drosophila Proteins
  • Eye Proteins
  • FOXO protein, Drosophila
  • Flavonols
  • Forkhead Transcription Factors
  • Repressor Proteins
  • dihydromyricetin